A multicenter evaluation of a novel microfluidic rapid AST assay for Gram-negative bloodstream infections
Journal of Clinical Microbiology · 16.10.2024 · 62 (10)
DOI: 10.1128/jcm.00458-24 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Clinical Microbiology, erschienen am 16.10.2024. Verfasst von Benjamin Berinson und 17 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Microbial Sensitivity Tests, Gram-Negative Bacterial Infections, Gram-Negative Bacteria. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tillväxtverket (Swedish Agency for Economic and Regional Growth).
Abstract (Originalsprache)
Common phenotypic methods for antimicrobial susceptibility testing (AST) of bacteria are slow, labor intensive, and display considerable technical variability. The QuickMIC system provides rapid AST using a microfluidic linear gradient. Here, we evaluate the performance of QuickMIC at four different laboratories with regard to speed, precision, accuracy, and reproducibility in comparison to broth microdilution (BMD). Spiked ( n = 411) and clinical blood cultures ( n = 148) were tested with the QuickMIC Gram-negative panel and compared with BMD for the 12 on-panel antibiotics, and 10 defined strains were run at each site to measure reproducibility. Logistic and linear regression analysis was applied to explore factors affecting assay performance. The overall essential agreement and categorical agreement between QuickMIC and BMD were 95.6% and 96.0%, respectively. Very major error, major error, and minor error rates were 1.0%, 0.6%, and 2.4%, respectively. Inter-laboratory reproducibility between the sites was high at 98.9% using the acceptable standard of ±1 twofold dilution. The mean in-instrument analysis time overall was 3 h 13 min (SD: 29 min). Regression analysis indicated that QuickMIC is robust with regard to initial inoculum and delay time after blood culture positivity. We conclude that QuickMIC can be used to rapidly measure MIC directly from blood cultures in clinical settings with high reproducibility, precision, and accuracy. The microfluidics-generated linear gradient ensures high reproducibility between laboratories, thus allowing a high level of trust in MIC values from single testing, at the cost of reduced measurement range compared to BMD. IMPORTANCE Increasing antimicrobial resistance underscores the need for new diagnostic solutions to guide therapy, but traditional antimicrobial susceptibility testing (AST) is often inadequate in time-critical diseases such as sepsis. This work presents a novel and rapid AST system with a rapid turnaround of results, which may help reduce the time to guided therapy, possibly allowing early de-escalation of broad-spectrum empirical therapy as well as rapid adjustments to treatments when coverage is lacking.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Gradientech AB, Uppsala, Sweden.
- Department of Clinical Microbiology, Uppsala University Hospital, Uppsala, Sweden.
- Department of Laboratory Medicine, Clinical Microbiology, Örebro University Hospital, Örebro, Sweden.
- Department of Laboratory Medicine, Clinical Microbiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
- Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
ORCID-Profile: Benjamin Berinson, Cecilia Johansson, Holger Rohde, Christer Malmberg
Förderung
- Tillväxtverket (Swedish Agency for Economic and Regional Growth)
Zitieren
APA
Berinson, B., Davies, E., Torpner, J., Flinkfeldt, L., Fernberg, J., Åman, A., Bergqvist, J., Öhrn, H., Ångström, J., Johansson, C., Jäder, K., Andersson, H., Ghaderi, E., Rolf, M., Sundqvist, M., Rohde, H., Fernandez-Zafra, T., & Malmberg, C. (2024). A multicenter evaluation of a novel microfluidic rapid AST assay for Gram-negative bloodstream infections. Journal of Clinical Microbiology, 62(10). https://doi.org/10.1128/jcm.00458-24
Vancouver
Berinson B, Davies E, Torpner J, Flinkfeldt L, Fernberg J, Åman A, et al. A multicenter evaluation of a novel microfluidic rapid AST assay for Gram-negative bloodstream infections. Journal of Clinical Microbiology. 2024;62(10). doi:10.1128/jcm.00458-24
BibTeX
@article{Berinson2024,
author = {Berinson, Benjamin and Davies, Emma and Torpner, Jessie and Flinkfeldt, Linnea and Fernberg, Jenny and Åman, Amanda and Bergqvist, Johan and Öhrn, Håkan and Ångström, Jonas and Johansson, Cecilia and Jäder, Klara and Andersson, Helena and Ghaderi, Ehsan and Rolf, Maria and Sundqvist, Martin and Rohde, Holger and Fernandez-Zafra, Teresa and Malmberg, Christer},
title = {A multicenter evaluation of a novel microfluidic rapid AST assay for Gram-negative bloodstream infections},
journal = {Journal of Clinical Microbiology},
year = {2024},
volume = {62},
number = {10},
doi = {10.1128/jcm.00458-24}
}
EUVIMED